It is noteworthy that CLSPN expression alone is predictive of increased patient survival (Figure 5H) and its enhanced expression in OAC compared to BO makes this a useful potential biomarker (Figure 5I). The gene discussed is CLSPN; the disease is bronchiolitis obliterans syndrome.